Journal article
Histone deacetylation contributes to low extracellular superoxide dismutase expression in human idiopathic pulmonary arterial hypertension
American journal of physiology. Lung cellular and molecular physiology, Vol.311(1), pp.L124-L134
07/01/2016
DOI: 10.1152/ajplung.00263.2015
PMCID: PMC4967185
PMID: 27233998
Abstract
Epigenetic mechanisms, including DNA methylation and histone acetylation, regulate gene expression in idiopathic pulmonary arterial hypertension (IPAH). These mechanisms can modulate expression of extracellular superoxide dismutase (SOD3 or EC-SOD), a key vascular antioxidant enzyme, and loss of vascular SOD3 worsens outcomes in animal models of pulmonary arterial hypertension. We hypothesized that SOD3 gene expression is decreased in patients with IPAH due to aberrant DNA methylation and/or histone deacetylation. We used lung tissue and pulmonary artery smooth muscle cells (PASMC) from subjects with IPAH at transplantation and from failed donors (FD). Lung SOD3 mRNA expression and activity was decreased in IPAH vs. FD. In contrast, mitochondrial SOD (Mn-SOD or SOD2) protein expression was unchanged and intracellular SOD activity was unchanged. Using bisulfite sequencing in genomic lung or PASMC DNA, we found the methylation status of the SOD3 promoter was similar between FD and IPAH. Furthermore, treatment with 5-aza-2'-deoxycytidine did not increase PASMC SOD3 mRNA, suggesting DNA methylation was not responsible for PASMC SOD3 expression. Though total histone deacetylase (HDAC) activity, histone acetyltransferase (HAT) activity, acetylated histones, and acetylated SP1 were similar between IPAH and FD, treatment with two selective class I HDAC inhibitors increased SOD3 only in IPAH PASMC. Class I HDAC3 siRNA also increased SOD3 expression. Trichostatin A, a pan-HDAC inhibitor, decreased proliferation in IPAH, but not in FD PASMC. These data indicate that histone deacetylation, specifically via class I HDAC3, decreases SOD3 expression in PASMC and HDAC inhibitors may protect IPAH in part by increasing PASMC SOD3 expression.
Details
- Title: Subtitle
- Histone deacetylation contributes to low extracellular superoxide dismutase expression in human idiopathic pulmonary arterial hypertension
- Creators
- Eva Nozik-Grayck - Department of Pediatrics, University of Colorado Anschutz Medical Center, Aurora, Colorado; Cardiovascular Pulmonary Research, University of Colorado Anschutz Medical Center, Aurora, Colorado; eva.grayck@ucdenver.eduCrystal Woods - Department of Pediatrics, University of Colorado Anschutz Medical Center, Aurora, Colorado; Cardiovascular Pulmonary Research, University of Colorado Anschutz Medical Center, Aurora, ColoradoRobert S Stearman - Department of Medicine, Indiana University, Indianapolis, Indiana; andSujatha Venkataraman - Department of Pediatrics, University of Colorado Anschutz Medical Center, Aurora, ColoradoBradley S Ferguson - Department of Medicine, University of Colorado Anschutz Medical Center, Aurora, ColoradoKalin Swain - Department of Pediatrics, University of Colorado Anschutz Medical Center, Aurora, Colorado; Cardiovascular Pulmonary Research, University of Colorado Anschutz Medical Center, Aurora, ColoradoRussell P Bowler - Department of Medicine, National Jewish Hospital, Denver, ColoradoMark W Geraci - Department of Medicine, Indiana University, Indianapolis, Indiana; andKaori Ihida-Stansbury - Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PennsylvaniaKurt R Stenmark - Department of Pediatrics, University of Colorado Anschutz Medical Center, Aurora, Colorado; Cardiovascular Pulmonary Research, University of Colorado Anschutz Medical Center, Aurora, Colorado; Department of Medicine, University of Colorado Anschutz Medical Center, Aurora, ColoradoTimothy A McKinsey - Department of Medicine, University of Colorado Anschutz Medical Center, Aurora, ColoradoFrederick E Domann - Department of Radiation Oncology, University of Iowa, Iowa City, Iowa
- Resource Type
- Journal article
- Publication Details
- American journal of physiology. Lung cellular and molecular physiology, Vol.311(1), pp.L124-L134
- DOI
- 10.1152/ajplung.00263.2015
- PMID
- 27233998
- PMCID
- PMC4967185
- NLM abbreviation
- Am J Physiol Lung Cell Mol Physiol
- ISSN
- 1040-0605
- eISSN
- 1522-1504
- Publisher
- American Physiological Society; United States
- Grant note
- R01 HL086680 / NHLBI NIH HHS T32 HL007171 / NHLBI NIH HHS R01 HL114887 / NHLBI NIH HHS R21 AG043822 / NIA NIH HHS R03 HL110783 / NHLBI NIH HHS R01 HL116848 / NHLBI NIH HHS F32 HL124893 / NHLBI NIH HHS P01 HL014985 / NHLBI NIH HHS R01 HL127240 / NHLBI NIH HHS
- Language
- English
- Date published
- 07/01/2016
- Academic Unit
- Pathology; Surgery; Radiation Oncology
- Record Identifier
- 9984047725902771
Metrics
18 Record Views